North China Pharmaceutical Company.Ltd (SHA:600812)

China flag China · Delayed Price · Currency is CNY
5.27
+0.02 (0.38%)
Apr 29, 2026, 3:00 PM CST
-9.91%
Market Cap 9.04B
Revenue (ttm) 8.82B
Net Income (ttm) 161.04M
Shares Out 1.72B
EPS (ttm) 0.09
PE Ratio 55.97
Forward PE n/a
Dividend 0.04 (0.67%)
Ex-Dividend Date n/a
Volume 9,004,792
Average Volume 24,142,041
Open 5.25
Previous Close 5.25
Day's Range 5.23 - 5.29
52-Week Range 5.01 - 7.46
Beta 0.43
RSI 40.79
Earnings Date Apr 18, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China. [Read more]

Sector Healthcare
Founded 1992
Employees 10,000
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600812
Full Company Profile

Financial Performance

In 2025, SHA:600812's revenue was 9.24 billion, a decrease of -6.36% compared to the previous year's 9.87 billion. Earnings were 183.06 million, an increase of 44.15%.

Financial Statements

News

There is no news available yet.